drugset / Trial / NCT00731601

Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding

NCT00731601

Phase 4 Completed 120 enrolled Lotung Poh-Ai Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

A large dose of PPI is effective in preventing peptic ulcer rebleeding. The investigators hypothesize that 40 mg/q6h pantoloc is equivalent to 8mg/h pantoloc in preventing rebleeding.

Timeline

Start
2008-05
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pantoprazole Other / unclassified 8 mg Intravenous
Comparator Pantoprazole Other / unclassified 40 mg Intravenous

Indications